Form 8-K - Current report:
SEC Accession No. 0001641172-25-015782
Filing Date
2025-06-20
Accepted
2025-06-20 13:28:11
Documents
13
Period of Report
2025-06-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 38643
  Complete submission text file 0001641172-25-015782.txt   206062

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE exoz-20250617.xsd EX-101.SCH 3014
3 XBRL LABEL FILE exoz-20250617_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE exoz-20250617_pre.xml EX-101.PRE 22358
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3767
Mailing Address 750 ROYAL OAKS DR MONROVIA CA 91016
Business Address 750 ROYAL OAKS DR MONROVIA CA 91016 (626) - 415 - 1488
EXOZYMES INC. (Filer) CIK: 0002010788 (see all company filings)

EIN.: 834550057 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42204 | Film No.: 251060430
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)